Evidence map›Paper›PMID 40117765›Full record

ArticlePsychiatry research2025

Neuro- and social-cognition in schizotypal personality disorder and schizophrenia: A spectrum of severity.

Kim E Goldstein, Robert H Pietrzak, Sana Aladin, Sabrina Ng, Chi C Chan, M Mercedes Perez-Rodriguez, Keith M Shafritz, René S Kahn, Margaret M McClure, Philip R Szeszko and 1 more

Abstract read
In one paragraph

Article in Psychiatry research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Aberrant effective connectivity during working memory performance in schizotypal personality disorder and schizophrenia: A spectrum approach.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kim E GoldsteinDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: kim.zinn@mssm.edu.
Robert H PietrzakUnited States Department of Veterans Affairs National Center for PTSD, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Sana AladinDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Sabrina NgDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Chi C ChanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
M Mercedes Perez-RodriguezDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Keith M ShafritzDepartment of Psychology, Hofstra University, Hempstead, NY, USA; Institute of Behavioral Science, Feinstein Institutes of Medical Research, Northwell Health, Manhasset, NY, USA.
René S KahnDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Margaret M McClureDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Psychology, Fairfield University, Fairfield, CT, USA.
Philip R SzeszkoDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA; James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.
Erin A HazlettDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA; James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA.

Funding

Longitudinal neuroimaging and neurocognitive assessment of risk and protective factors across the schizophrenia spectrumR01MH121411 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAZLETT, ERIN A., SZESZKO, PHILIP R · 2020 to 2024
$4.8M
CSRD VA IK6 CX001738CSRD VA IK6 CX002700NIMH NIH HHS R01 MH121411
6 · The paper itself

Abstract

Despite the significant number of impairments shared by diagnostic groups on the schizophrenia-phenotypic-spectrum, no work has directly compared neuro- and social-cognition of individuals with schizotypal personality disorder (SPD) with that of schizophrenia. This is the first study to compare social-cognition and neuro-cognition across schizophrenia-spectrum-diagnostic groups and explore associations (1) between neuro- and social-cognition in these groups and (2) between change-over-time (nine-month follow-up) in cognition and negative-symptom-severity. This study identified 127 age- and gender-matched healthy controls (HC; N = 49), antipsychotic-naïve individuals with SPD (N = 32), and patients with recent onset schizophrenia (within eight years of illness-onset; N = 46). Detailed profiles of clinical symptoms and cognition were obtained using gold-standard measures (e.g., NIH MATRICS Battery). Schizophrenia patients exhibited global cognitive impairment; SPD patients only exhibited impairment in social-emotional cognition compared with HC (Cohen d = 0.51) but still performed better than the schizophrenia group F[2, 124]=15.18, p < 0.001, Cohen d = 0.61. Multivariable linear regression revealed that social-cognition was associated with neuro-cognition, β=0.49, p < 0.001. In the combined patient group, a greater increase in social-cognition over time was associated with greater reduction in negative symptoms, (B = -0.12, SE=0.09, p = 0.038). Distinct profiles emerged: generalized cognitive impairment in schizophrenia and higher-order social-cognition impairment in SPD. Furthermore, change in social-cognition over time is associated with a change in negative symptoms. Results suggest that social-cognition is impaired across the schizophrenia-spectrum, and detailed examination of social-cognitive treatments should be considered, particularly for individuals with SPD, as they receive minimal attention in research studies.

Indexed as

Cognitive DysfunctionSchizophreniaSchizophrenic PsychologySchizotypal Personality DisorderSocial CognitionAdultFemaleHumansMaleMiddle AgedNeuropsychological TestsSeverity of Illness IndexYoung AdultNeuropsychologyProblem-solvingSchizophreniaSocial-cognition

Identifiers

PMID40117765
PMCPMC12265923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.